Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Lung Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Lung Cancer
    Gefitinib Approved in EU for Locally Advanced, Metastatic NSCLC - (DGNews)
    TopAbstracts in Lung Cancer 06/24/2009 - (DGNews)
    TopAbstracts in Lung Cancer 06/10/2009 - (DGNews)
    Prophylactic Cranial Irradiation Has No Impact on Overall Survival in Patients With NSCLC Brain Metastases: Presented at ASCO - (DGDispatch)
    Vandetanib Plus Docetaxel Combination Prolongs Progression-Free Survival in Patients With Non-Small-Cell Lung Cancer: Presented at ASCO - (DGDispatch)

    News archive

     Recent webcasts/CME - Lung Cancer
  • Latest Data From Chicago Provide New Insight Into the Evolving Role of Cytotoxic and Targeted Therapies in Early-Stage NSCLC
  • Silica-Related Lung Disease: It's Still Here

    Webcasts/CME archive

     Recent cases - Lung Cancer
      Diffuse Interstitial Lung Disease Related to Peribronchiolar Metaplasia
      Isolated Pancreatic Metastases from a Bronchogenic Small Cell Carcinoma
      High-Resolution Computed Tomography Illustrating Pulmonary Lymphangitic Carcinomatosis in a Patient with Advanced Pancreatic Cancer: A Case Report
      Mesothelioma in an HIV/AIDS Patient Without History of Asbestos Exposure: Possible Role For Immunosuppression in Mesothelioma: A Case Report
      Pulmonary Lymphoma Mimicking Metastases: A Case Report

      Cases archive
        




      my personal edition > lung cancer > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Solitary Pulmonary Nodules Stable for 2 Years Need Not Be Treated: Presented at CHEST

        By John Gever

        CHICAGO, IL -- October 25, 2007 -- Fifty-year-old advice on management of solitary pulmonary nodules (SPN) is accurate despite controversy over the original studies, according to research presented here at CHEST 2007, the annual meeting of the American College of Chest Physicians.

        Research published in the mid-1950s led to widespread belief that SPNs that remained stable for 2 years were benign and need not be removed or otherwise treated. However, this belief has recently come into question, and had not been tested systematically with more current data.

        Now, new data confirm that stable SPNs are indeed almost always benign, said Nadim Daher, Pulmonary Fellow, Department of Pulmonary and Critical Care Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States, Speaking on October 23.

        His group reviewed records of all patients evaluated for SPNs between 1999 and 2007. Chest radiographs and computerised tomography images were analysed along with potential risk factors such as age and smoking status.

        The review yielded 42 patients who had a total of 44 SPNs that had been stable for at least 2 years during the study interval and with sufficient records for analysis. The mean followup interval was 1.4 years.

        Most lesions ranged from 0.5 to 2.5 cm in diameter; 70% had smooth margins. Most were solid and not calcified and were found in all areas of the lung.

        Of the 42 patients, 40 survived with no change in SPN size or shape during the study period. One patient died more than 5 years after the nodule was first identified, with no change seen in the SPN at autopsy. In one patient, the SPN was seen to grow with a doubling time of 1,719 days, according to Dr. Daher, who said that doubling times for malignant lesions are typically in the range of 20 to 400 days.

        He said these data support the long-held belief that SPNs remaining stable for 2 years do not require further evaluation or treatment.

        [Presentation title: Radiographic Follow-Up of Stable Lung Nodules. Session 921]




      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send